Active Recombinant Human EFNA2 Protein, Fc Chimera

• Cat.No.: EFNA2-978H
• Product Overview: Recombinant Human EFNA2 (Accession # O43921), fused with , was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Tag: Fc
• Predicted N Terminal: Starts at Glu27
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its ability to inhibit proliferation of PC-3 human prostate cancer cells.The ED50 for this effect is typically 5-25 ng/mL.
• Molecular Mass: Recombinant Human EFNA2, Fc Chimera has a calculated MW of 45.1 kDa (monomer). In SDS-PAGE migrates as 55-60 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Reconstitution: Reconstitute at 25 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.

Gene Information

• Gene Name: EFNA2 ephrin-A2 [ Homo sapiens ]
• Official Symbol: EFNA2
• Synonyms: EFNA2; ephrin-A2; EPLG6; ELF 1; LERK6; HEK7 ligand; eph-related receptor tyrosine kinase ligand 6; ELF-1; HEK7-L; LERK-6
• Gene ID: 1943
• mRNA Refseq: NM_001405
• Protein Refseq: NP_001396
• MIM: 602756
• UniProt ID: O43921
• Chromosome Location: 19p13